A Randomized, Double-blind, Placebo-controlled Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of SAR279356 in Patients Hospitalized in Intensive Care Unit and on Mechanical Ventilation.
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2014
At a glance
- Drugs F-598 (Primary)
- Indications Bacterial infections; Nosocomial infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Sanofi
- 01 Dec 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Nov 2012 Planned End Date changed from 1 Dec 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 29 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.